Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?
Cortinovis D, Bidoli P, Cullurà D, Lorusso V, Ardizzoia A, Amoroso V, Bandera M, Aitini E, Fusi A, Zilembo N, Radula D, Bajetta E.
Cortinovis D, et al.
J Thorac Oncol. 2008 Apr;3(4):405-11. doi: 10.1097/JTO.0b013e318168f780.
J Thorac Oncol. 2008.
PMID: 18379360
Free article.
Clinical Trial.